|
LOBBYING REPORT |
Lobbying Disclosure Act of 1995 (Section 5) - All Filers Are Required to Complete This Page
2. Address
| Address1 | 200 Lawyers Road NW #1506 |
Address2 |
|
| City | Vienna |
State | VA |
Zip Code | 22183 |
Country | USA |
3. Principal place of business (if different than line 2)
| City |
|
State |
|
Zip Code |
|
Country |
|
|
5. Senate ID# 35627-12
|
||||||||
|
6. House ID# 327060000
|
||||||||
| TYPE OF REPORT | 8. Year | 2023 |
Q1 (1/1 - 3/31) | Q2 (4/1 - 6/30) | Q3 (7/1 - 9/30) | Q4 (10/1 - 12/31) |
9. Check if this filing amends a previously filed version of this report
| 10. Check if this is a Termination Report | Termination Date |
|
11. No Lobbying Issue Activity |
| INCOME OR EXPENSES - YOU MUST complete either Line 12 or Line 13 | |||||||||
|---|---|---|---|---|---|---|---|---|---|
| 12. Lobbying | 13. Organizations | ||||||||
| INCOME relating to lobbying activities for this reporting period was: | EXPENSE relating to lobbying activities for this reporting period were: | ||||||||
|
|
||||||||
|
|
||||||||
| Provide a good faith estimate, rounded to the nearest $10,000, of all lobbying related income for the client (including all payments to the registrant by any other entity for lobbying activities on behalf of the client). | 14. REPORTING Check box to indicate expense accounting method. See instructions for description of options. | ||||||||
|
Method A.
Reporting amounts using LDA definitions only
Method B. Reporting amounts under section 6033(b)(8) of the Internal Revenue Code Method C. Reporting amounts under section 162(e) of the Internal Revenue Code |
|||||||||
| Signature | Digitally Signed By: Karen Kerrigan |
Date | 7/19/2023 11:27:44 PM |
LOBBYING ACTIVITY. Select as many codes as necessary to reflect the general issue areas in which the registrant engaged in lobbying on behalf of the client during the reporting period. Using a separate page for each code, provide information as requested. Add additional page(s) as needed.
15. General issue area code SMB
16. Specific lobbying issues
Taxes and Tax Reform
R&D Tax Credit: Continue to support extending and making permanent full expensing for R&D expenditures for small businesses. Voiced Support for "American Innovation and Jobs Act" in the Senate and "American Innovation and R&D Competitiveness Act" in the House.
"Small Business Jobs Act" (HR 3937) - Voiced support for Ways and Means passage of the legislation.
"Build It in America Act" (HR 3938) - Voiced support for Ways and Means passage of the legislation.
"Small Business Investment Act" - Voiced support for the bill and reforming Section 1202 of the tax code.
Death Tax Repeal Act of 2023: Support House and Senate bills to permanent repeal the death tax.
Capital Gains Tax Indexing - Voiced support for this reform measure.
Fiscal Policy and Debt Ceiling
"Fiscal Accountability Act" - Supported House and Senate passage.
Affordable Health Coverage and Health Care Innovation
"CHOICE Arrangement Act" (H.R. 2799) - Supported House passage.
Tax Credit for Small Businesses: Support making reforms to the restrictive and temporary health care tax credit for small businesses to make it more practical for small businesses.
Provided House Ways and Means Testimony on Health Care and Small Business: Voiced ongoing concerns about the rising costs of health coverage, lack of choices, and dwindling choices in many markets against the backdrop of challenging economic conditions. Voiced support for these various reforms: enhancing tax credits for small businesses, expanding and making additional fixes to HSAs, reforming QSEHRAs, and making CARESs Act telehealth provisions permanent.
"Telehealth Expansion Act of 2023" (H.R. 1843) - Voiced support for Ways and Means Committee passage.
Chronic Disease Flexible Coverage Act (H.R. 3800) - Voiced support for Ways and Means Committee passage.
Paperwork Burden Reduction Act (H.R. 3797) - Voiced support for Ways and Means Committee passage.
Employer Reporting Improvement Act (H.R. 3801) - Voiced support for Ways and Means Committee passage.
Small Business Flexibility Act (H.R. 3798) - Voiced support for Ways and Means Committee passage.
Custom Health Option and Individual Care Expense Arrangement Act (H.R. 3799) - Voiced support for Ways and Means Committee passage.
Inflation Reduction Act and Pharmaceuticals: Expressed concern about the impact of price controls on drug innovation, especially for small bio-pharmaceutical firms.
SMART Prices Act (S. 1264) - Oppose the legislation.
Expressed concern about initial implementation guidance for the Medicare Drug Price Negotiation Program established by the Inflation Reduction Act (IRA) by the Centers for Medicare & Medicaid Services (CMS) and its impact on small bio-pharmaceutical firms.
Waiver Expansion for U.S. Developed Covid-19 Diagnostics and Therapeutics - Opposed such a waiver in comments to U.S. International Trade Commission in its Investigation No. 332-596.
Access to Broadband and Digital Policy
Development of a National Spectrum Strategy (NSS) - Expressed support for such a policy to the National Telecommunications Information Administration (NTIA).
Broadband Infrastructure: Support efforts in the Congress to provide oversight and track Broadband Equity, Access and Deployment (BEAD) Program funding to ensure the tens of billions of taxpayer dollars being allocated will be used efficiently to connect those lacking access with high-speed broadband.
Regulation
"Regulations from the Executive in Need of Scrutiny (REINS) Act" (H.R. 277) - Supported House passage.
Save Our Gas Stoves Act (H.R. 1640)- Supported House passage.
"American Innovation and Choice Online Act" (S.2033): Oppose the legislation.
Cloud Computing: Provided comments to the Federal Trade Commission on the Business Practices of Cloud Computing Providers, urging caution and understanding about the small business role in this industry and the benefits of cloud computing to small businesses, which have voiced no concerns about the purpose of the FTC's review of this issue.
Labor and Workforce Policy
"Save Local Businesses Act" (S.1261, HR 2826) - Support the legislation.
Paid Leave Policy in U.S. House: Continue to express support for bipartisan exploration in identifying paid leave policy solutions that help support business owners and working families.
Nomination of Julie Su as DOL Labor Secretary: Oppose the nomination.
Proposed Independent Contractor Rules: Continued to express opposition to independent contractor rules being proposed and advanced by the Department of Labor.
"Protecting the Right to Organize (PRO) Act" (S. 567) - Oppose the legislation.
"Healthy Families Act" (S.1664) - Oppose the legislation.
"Paycheck Fairness Act" (S. 728) - Oppose the legislation.
Intellectual Property
Provided input to the United States Patent and Trademark Office on an Advance Notice of Proposed Rulemaking (ANPRM) on potential reforms to Patent Trial and Appeal Board (PTAB) proceedings, urging USPTO to return PTAB to its original purpose.
17. House(s) of Congress and Federal agencies Check if None
U.S. SENATE, U.S. HOUSE OF REPRESENTATIVES, Federal Trade Commission (FTC), Centers For Medicare and Medicaid Services (CMS), U.S. International Trade Commission (ITC), Patent & Trademark Office (PTO)
18. Name of each individual who acted as a lobbyist in this issue area
| First Name | Last Name | Suffix | Covered Official Position (if applicable) | New |
Karen |
Kerrigan |
|
|
|
Raymond |
Keating |
|
|
19. Interest of each foreign entity in the specific issues listed on line 16 above Check if None
Information Update Page - Complete ONLY where registration information has changed.
20. Client new address
| Address |
|
||||||
| City |
|
State |
|
Zip Code |
|
Country |
|
21. Client new principal place of business (if different than line 20)
| City |
|
State |
|
Zip Code |
|
Country |
|
22. New General description of client’s business or activities
LOBBYIST UPDATE
23. Name of each previously reported individual who is no longer expected to act as a lobbyist for the client
|
|
||||||||
| 1 |
|
3 |
|
||||||
| 2 |
|
4 |
|
ISSUE UPDATE
24. General lobbying issue that no longer pertains
|
|
|
|
|
|
|
|
|
AFFILIATED ORGANIZATIONS
25. Add the following affiliated organization(s)
Internet Address:
| Name | Address |
Principal Place of Business (city and state or country) |
||||||||||||
| ||||||||||||||
|
||||||||||||||
26. Name of each previously reported organization that is no longer affiliated with the registrant or client
| 1 | 2 | 3 |
FOREIGN ENTITIES
27. Add the following foreign entities:
| Name | Address |
Principal place of business (city and state or country) |
Amount of contribution for lobbying activities | Ownership percentage in client | ||||||||||
| ||||||||||||||
|
% | |||||||||||||
28. Name of each previously reported foreign entity that no longer owns, or controls, or is affiliated with the registrant, client or affiliated organization
| 1 | 3 | 5 |
| 2 | 4 | 6 |
CONVICTIONS DISCLOSURE
29. Have any of the lobbyists listed on this report been convicted in a Federal or State Court of an offense involving bribery,
extortion, embezzlement, an illegal kickback, tax evasion, fraud, a conflict of interest, making a false statement, perjury, or money laundering?
| Lobbyist Name | Description of Offense(s) |